A new study from research firm IMS shows that new and better treatments for disease and a dip in physician visits steadied health care spending in the United States last year. It should be considered good news for a country…
Thoratec Corporation (NASDAQ: THOR) took it on the chin today after news came out about the Food & Drug Administration recalling the company’s HeartMate II as the left ventricular-assist system. What is interesting is that the FDA…
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it pertains to Hepatitis C…
Pacific Biosciences of California, Inc. (NASDAQ: PACB) has just filed paperwork with the Securities and Exchange Commission to raise up to $150 million in a mixed securities shelf registration statement. The filing will allow…
Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) is the NASDAQ pre-market leader this morning on news that its subcutaneous SGI-110 interim phase I.II MDS and AML data demonstrated differentiated PK profile and good tolerability, as well…
Stemline Therapeutics, Inc. has just filed its paperwork with the Securities and Exchange Commission that will allow it to conduct an initial public offering. The company will list is shares under the ticker “STML” on…
Theravance Inc. (NASDAQ: THRX) got a big boost today from a purchase of 10 million additional shares by GlaxoSmithKline plc (NYSE: GSK) at a 7.5% premium to a volume-weighted average share price for the…
Isn’t the current administration’s watch-dog policy supposed to police mergers and acquisitions in regards to competition and pricing power? Many industry watch groups have been opposed to the merger where Medco Health Solutions, Inc.…
The $29.1 billion merger between Express Scripts Inc. (NASDAQ: ESRX) and Medco Health Solutions Inc. has been cleared by the Federal Trade Commission (FTC) and the companies have announced that the completion of the…
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) this morning announced that its colorectal cancer treatment did no better than placebo in a Phase 3 trial. The company said it will evaluate whether or not to continue…
If there is one sector you can count on to raise capital either after opportunistic share price gains or at the worst prices seen in years it is the emerging pharma sector. A small company…
Oracle Corp. (NASDAQ: ORCL) has announced that it will acquire ClearTrial, a maker of cloud-based Clinical Trial Operations applications for an undisclosed sum. The transaction is expected to close in the first half of…
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning. News hit that the FDA has now rejected the company’s Northera drug to treat low blood pressure for now in a complete…
Globus Medical, Inc. is the latest of the companies filing with the Securities and Exchange Commission to come public via an initial public offering. No terms were projected yet but the company’s filing is…
Shares of diagnostics company Vermillion Inc. (NASDAQ: VRML) have jumped more than 20% this morning following the company’s announcement of a patent approval for another of its biomarkers used to diagnose ovarian cancer. Today’s…